Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Defina

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.
British Journal of Haematology|November 6, 2022
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL studyMichelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, et al.
Journal of Clinical Medicine|October 24, 2020
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in CaucasiansIlaria Mancini, Elisa Giacomini, Silvia Pontiggia, et al.
Annals of Hematology|August 26, 2025
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL groupDavide Lazzarotto, Anna Maria Testi, Matteo Fanin, et al.
Bone Marrow Transplantation|June 2, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL studyGianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, et al.
Hematological Oncology|August 7, 2019
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapyMonica Bocchia, Anna Candoni, Erika Borlenghi, et al.
Haematologica|January 15, 2026
Real-life management of 476 older adults with Philadelphianegative acute lymphoblastic leukemia: a Campus ALL studyMarco Cerrano, Davide Lazzarotto, Eleonora Boscaro, et al.
Haematologica|August 19, 2024
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL studyDavide Lazzarotto, Marco Cerrano, Cristina Papayannidis, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.
British Journal of Haematology|November 6, 2022
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL studyMichelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, et al.
Journal of Clinical Medicine|October 24, 2020
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in CaucasiansIlaria Mancini, Elisa Giacomini, Silvia Pontiggia, et al.
Annals of Hematology|August 26, 2025
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL groupDavide Lazzarotto, Anna Maria Testi, Matteo Fanin, et al.
Bone Marrow Transplantation|June 2, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL studyGianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, et al.
Hematological Oncology|August 7, 2019
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapyMonica Bocchia, Anna Candoni, Erika Borlenghi, et al.
Haematologica|January 15, 2026
Real-life management of 476 older adults with Philadelphianegative acute lymphoblastic leukemia: a Campus ALL studyMarco Cerrano, Davide Lazzarotto, Eleonora Boscaro, et al.
Haematologica|August 19, 2024
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL studyDavide Lazzarotto, Marco Cerrano, Cristina Papayannidis, et al.
Pageof 7